 CARLSBAD, Calif., April 15, 2021 GLOBE NEWSWIRE -- SeaSpine Holdings Corporation NASDAQ: SPNE SeaSpine or the Company, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock at a public offering price of 19.50 per share. The gross proceeds to SeaSpine, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately 87.8 million. The offering is expected to close on or about April 20, 2021, subject to customary closing conditions. 